We are live on ! Find out more
RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $47.9M
1-Year Est. Return 29.29%
This Fund
S&P 500
This Quarter Est. Return
+13.83%
1 Year Est. Return
+29.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$140M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$38.5B
$1.2B 97.23%
4,444,445
– –
NTLA icon
2
Intellia Therapeutics
NTLA
$1.82B
$26.3M 2.13%
3,702,995
– –
TSVT
3
DELISTED
2seventy bio
TSVT
$6.2M 0.5%
1,254,827
– –
ADVM
4
DELISTED
Adverum Biotechnologies
ADVM
$791K 0.06%
180,909
– –
ACET icon
5
Adicet Bio
ACET
$79.9M
$731K 0.06%
60,511
– –
BLUE
6
DELISTED
bluebird bio
BLUE
$102K 0.01%
21,000
– –

Similar funds

PFA
Portland Financial Advisors Port Washington, New York $48.1M AUM 10.13% 1-Year Est. Return
CCG
Capital CS Group Irvine, California $48.4M AUM 11.64% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
FWM
FLP Wealth Management Bentonville, Arkansas $48.5M AUM 23.48% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $48.6M AUM 13.34% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $47.1M AUM 78.22% 1-Year Est. Return
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return